메뉴바로가기 본문바로가기

R&D center

인류의 안전과 건강 증진에 기여하는 기업, (주)인테라입니다.

InThera R&D Center continues its dedicated research and development of VLP-based innovative vaccines

01INTHERA R&D Center
  • Registration date : Jan 17, 2018
  • Location : TechnoCube #1103, Seoul National University, Seoul, Korea
  • R&D task : Manufacturing process development of recombinant virus vaccines
Key technology 02
  • Development of engineered host cell for soluble
    expression of virus capsid proteins.
  • Cost-effective process by using high density
    fermentation and efficient purification.
  • Virus like particle assembly process for vaccine API.
  • Physicochemical analysis of virus like particles.
03Research facility
  • Most of the equipment for research & development are secured in R&D center
Purpose Instrument
Host cell development PCR, Electrophoresis, Gel-documentation system
Fermentation Shaking incubator, 5 L Fermentor, Microscope
Protein purification Sonicator, AKTA Prime FPLC
Protein and VLP analysis
(*out-sourced)
PAGE, Western blot, ELISA, HPLC, DLS, EM*
Common purpose Autoclave, pH meter, Balance, SDS-PAGE
UV-Vis spectrophotometer
High-speed centrifuge
Deep freezer, Laminar flow bench
Ultra pure water generator
Cold chamber and refrigerator